Cite
MLA Citation
Evan S. Dellon et al.. “A Randomized, Double‐Blind, Placebo‐Controlled Trial of a Novel Recombinant, Humanized, Anti‐Interleukin‐13 Monoclonal Antibody (RPC4046) in Patients with Active Eosinophilic Esophagitis: Results of the HEROES Study.” American journal of gastroenterology, vol. 111, n.d., p. . http://access.bl.uk/ark:/81055/vdc_100122851563.0x00005b